| scholarly article | Q13442814 |
| P2093 | author name string | Howard A Reber | |
| O Joe Hines | |||
| Eliane Angst | |||
| Guido Eibl | |||
| Michelle Mojadidi | |||
| Monica Chen | |||
| P2860 | cites work | Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria. | Q54770050 |
| A xenograft nude mouse model for perineural invasion and recurrence in pancreatic cancer | Q81216392 | ||
| Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer | Q24801511 | ||
| Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition | Q28238040 | ||
| Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice | Q28593600 | ||
| Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase | Q28646403 | ||
| Angiogenesis: an organizing principle for drug discovery? | Q29614538 | ||
| Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse | Q31002708 | ||
| Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography | Q33318187 | ||
| Imaging angiogenesis and the microenvironment | Q33811205 | ||
| VEGF receptor signal transduction | Q34461939 | ||
| Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. | Q35796234 | ||
| Overexpression of VEGF in testis and epididymis causes infertility in transgenic mice: evidence for nonendothelial targets for VEGF. | Q36255954 | ||
| Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis | Q36335555 | ||
| Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch | Q36576720 | ||
| Targeted in vivo imaging of angiogenesis: present status and perspectives | Q36724070 | ||
| Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. | Q37133833 | ||
| Coregistration of ultrasonography and magnetic resonance imaging with a preliminary investigation of the spatial colocalization of vascular endothelial growth factor receptor 2 expression and tumor perfusion in a murine tumor model | Q37335861 | ||
| Color-coded fluorescent protein imaging of angiogenesis: the AngioMouse models | Q37364050 | ||
| Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects | Q40024036 | ||
| Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature | Q40187867 | ||
| VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer. | Q40464915 | ||
| Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models | Q40556196 | ||
| Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer | Q42435064 | ||
| A molecular imaging paradigm to rapidly profile response to angiogenesis-directed therapy in small animals | Q43135196 | ||
| Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression | Q44703752 | ||
| Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer | Q46781781 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 2.0 Generic | Q44128984 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P921 | main subject | bioluminescence | Q179924 |
| pancreatic cancer | Q212961 | ||
| angiogenesis | Q539568 | ||
| P304 | page(s) | 570-575 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Molecular Imaging and Biology | Q6895951 |
| P1476 | title | Bioluminescence imaging of angiogenesis in a murine orthotopic pancreatic cancer model | |
| P478 | volume | 12 |
| Q28538698 | An optimized triple modality reporter for quantitative in vivo tumor imaging and therapy evaluation |
| Q37073750 | Bioluminescent orthotopic model of pancreatic cancer progression. |
| Q50090332 | Expression of VEGFR-2 during Liver Regeneration after Partial Hepatectomy in a Bioluminescence Mouse Model |
| Q34949654 | In vivo monitoring of angiogenesis inhibition via down-regulation of mir-21 in a VEGFR2-luc murine breast cancer model using bioluminescent imaging |
| Q34881746 | In vivo monitoring of fetoplacental Vegfr2 gene activity in a murine pregnancy model using a Vegfr2-luc reporter gene and bioluminescent imaging. |
| Q36146407 | Multimodal Genetic Approach for Molecular Imaging of Vasculature in a Mouse Model of Melanoma |
| Q38089102 | Non-invasive molecular imaging for preclinical cancer therapeutic development. |
| Q54590218 | [Identification of the offspring of Vegfr2-luc transgenic mouse]. |
Search more.